BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Craanen ME, Blok P, Top B, Boerrigter L, Dekker W, Offerhaus GJ, Tytgat GN, Rodenhuis S. Absence of ras gene mutations in early gastric carcinomas. Gut. 1995;37:758-762. [PMID: 8537044 DOI: 10.1136/gut.37.6.758] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Jabini R, Eghbali SA, Ayatollahi H, Sheikhi M, Farzanehfar M. Analysis of KRAS gene mutation associated with Helicobacter pylori infection in patients with gastric cancer. Iran J Basic Med Sci 2019;22:529-33. [PMID: 31217933 DOI: 10.22038/ijbms.2019.32047.7707] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Blok, Craanen, Dekker, Offerhaus, Tytgat. No evidence for c‐ erb B‐2 overexpression in gastric carcinogenesis. Histopathology 2001;32:335-9. [DOI: 10.1046/j.1365-2559.1998.00376.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
3 Blok P, Craanen ME, Dekker W, Tytgat GN. Loss of E-cadherin expression in early gastric cancer. Histopathology. 1999;34:410-415. [PMID: 10231415 DOI: 10.1046/j.1365-2559.1999.00652.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.5] [Reference Citation Analysis]
4 Meuwissen SG, Craanen ME, Kuipers EJ. Gastric mucosal morphological consequences of acid suppression: a balanced view.Best Pract Res Clin Gastroenterol. 2001;15:497-510. [PMID: 11403542 DOI: 10.1053/bega.2001.0189] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
5 Nan HM, Song YJ, Yun HY, Park JS, Kim H. Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer. World J Gastroenterol 2005; 11(25): 3834-3841 [PMID: 15991278 DOI: 10.3748/wjg.v11.i25.3834] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
6 Blok P, Craanen ME, van Diest PJ, Dekker W, Tytgat GN. Lack of cyclin D1 overexpression in gastric carcinogenesis. Histopathology 2000;36:151-5. [PMID: 10672060 DOI: 10.1046/j.1365-2559.2000.00798.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
7 Lord RV, O'Grady R, Sheehan C, Field AF, Ward RL. K-ras codon 12 mutations in Barrett's oesophagus and adenocarcinomas of the oesophagus and oesophagogastric junction. J Gastroenterol Hepatol 2000;15:730-6. [PMID: 10937677 DOI: 10.1046/j.1440-1746.2000.02163.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 2.1] [Reference Citation Analysis]
8 Sgambato A, Migaldi M, Leocata P, Ventura L, Criscuolo M, Di Giacomo C, Capelli G, Cittadini A, De Gaetani C. Loss of p27Kip1 expression is a strong independent prognostic factor of reduced survival in N0 gastric carcinomas. Cancer 2000;89:2247-57. [DOI: 10.1002/1097-0142(20001201)89:11<2247::aid-cncr13>3.0.co;2-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
9 Craanen ME, Blok P, Offerhaus GJ, Meijer GA, Dekker W, Kuipers EJ, Meuwissen SG. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis. J Pathol 1999;189:481-6. [PMID: 10629547 DOI: 10.1002/(SICI)1096-9896(199912)189:4<481::AID-PATH482>3.0.CO;2-U] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
10 Russo A, Bazan V, Migliavacca M, Tubiolo C, Macaluso M, Zanna I, Corsale S, Latteri F, Valerio MR, Pantuso G, Morello V, Dardanoni G, Latteri MA, Colucci G, Tomasino RM, Gebbia N. DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. Cancer 2001;92:294-302. [DOI: 10.1002/1097-0142(20010715)92:2<294::aid-cncr1322>3.0.co;2-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
11 Hu TZ, Huang LH, Xu CX, Liu XM, Wang Y, Xiao J, Zhou L, Luo L, Jiang XX. Expressional profiles of transcription factors in the progression of Helicobacter pylori-associated gastric carcinoma based on protein/DNA array analysis. Med Oncol. 2015;32:265. [PMID: 26563475 DOI: 10.1007/s12032-015-0711-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hailey JR, Haseman JK, Bucher JR, Radovsky E, Malarkey DE, Miller RT, Nyska A, Maronpot RR. Impact of Helicobacter hepaticus Infection in B6C3F 1 Mice from Twelve National Toxicology Program Two-Year Carcinogenesis Studies. Toxicol Pathol 1998;26:602-11. [DOI: 10.1177/019262339802600503] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 11.8] [Reference Citation Analysis]
13 Heideman DA, Snijders PJ, Bloemena E, Meijer CJ, Offerhaus GJ, Meuwissen SG, Gerritsen WR, Craanen ME. Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma. J Pathol 2001;194:428-35. [PMID: 11523050 DOI: 10.1002/path.934] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]